Skip to main content
. 2016 Oct 21;60(11):6766–6773. doi: 10.1128/AAC.00632-16

FIG 3.

FIG 3

Scatterplot of adjusted OR estimates and 95% CIs for 2-month culture positivity among patients with unsuspected MDR-TB receiving standard first-line antituberculous therapy, by pyrazinamide resistance assay and the consensus gold standard. The vertical dashed line indicates an odds ratio of 1 (no association). MGIT, mycobacteria growth indicator tube.